When.com Web Search

  1. Ads

    related to: newest treatment for psoriatic arthritis

Search results

  1. Results From The WOW.Com Content Network
  2. Apremilast - Wikipedia

    en.wikipedia.org/wiki/Apremilast

    Apremilast, sold under the brand name Otezla among others, is a medication for the treatment of certain types of psoriasis and psoriatic arthritis. [4] The drug acts as a selective inhibitor of the enzyme phosphodiesterase 4 (PDE4). [4] It is taken by mouth. [4]

  3. This Is the Difference Between Rheumatoid and Psoriatic Arthritis

    www.aol.com/difference-between-rheumatoid...

    “There are several good treatment paradigms for psoriatic arthritis, and the likelihood of severe deformity like there was in the past is close to zero with the new therapies we have,” Hylland ...

  4. Psoriatic arthritis - Wikipedia

    en.wikipedia.org/wiki/Psoriatic_arthritis

    Psoriatic arthritis tends to appear about 10 years after the first signs of psoriasis. [3] For the majority of people, this is between the ages of 30 and 55, but the disease can also affect children. The onset of psoriatic arthritis symptoms before symptoms of skin psoriasis is more common in children than adults. [48]

  5. Guselkumab - Wikipedia

    en.wikipedia.org/wiki/Guselkumab

    In April 2018, guselkumab was approved in Japan for the treatment of psoriatic arthritis. [19] In July 2020, the FDA approved guselkumab as the first IL-23 inhibitor to treat active psoriatic arthritis (PsA). [20] [21] In September 2024, the FDA approved guselkumab for the treatment of moderately to severely active ulcerative colitis in adults. [9]

  6. Secukinumab - Wikipedia

    en.wikipedia.org/wiki/Secukinumab

    Secukinumab, sold under the brand name Cosentyx among others, is a human IgG1κ monoclonal antibody used for the treatment of psoriasis, ankylosing spondylitis, and psoriatic arthritis. [4] [5] [6] It binds to the protein interleukin (IL)-17A and is marketed by Novartis. [4] [5] [6]

  7. Psoriatic Arthritis - AOL

    www.aol.com/news/psoriatic-arthritis-143510150.html

    For premium support please call: 800-290-4726 more ways to reach us

  1. Ads

    related to: newest treatment for psoriatic arthritis